SUE SMITH AND CRAIG BROWN ENDOWED POSTDOCTORAL FELLOWSHIPS

The Sue Smith and Craig Brown Endowed Postdoctoral Fellowship in Cancer immunology offers a prestigious research opportunity for highly motivated individuals who have recently achieved a M.D. or Ph.D. degree in cancer immunology or a related field. The successful candidate will conduct research at the Grattoni Laboratory at the acclaimed Houston Methodist Hospital located in the Texas Medical Center, the world’s largest medical complex at the forefront of medical innovation and research.  Research will focus on the development of innovative preventive vaccines and therapeutic devices and platforms harnessing the body’s immune system to successfully combat cancer.    

Overview: The Sue Smith and Craig Brown Endowed Postdoctoral Fellowship in Cancer Immunology is a prestigious opportunity for highly motivated individuals who have recently graduated with a Ph.D. or M.D. Ph.D. degree in cancer immunobiology or a related field (within a maximum of 2 years after obtaining their degree). This fellowship program is dedicated to the advancement of cancer immunology and immunotherapy, with a focus on the development of innovative preventive vaccines and therapeutic devices and platforms that harness the body’s own immune system to combat cancer effectively. The successful candidate will also have the opportunity to work at the forefront of cell engineering and explore the potential for local cell recruitment and reprogramming. This fellowship supports individuals to conduct research training in the Grattoni’s Laboratory at the Houston Methodist Hospital, in Houston Texas. Houston Methodist Hospital, situated in the heart of the Texas Medical Center, the world’s largest medical complex, is at the forefront of medical innovation and research. With a strong emphasis on translating cutting-edge biomedical technologies into clinical practice, it stands as a beacon of excellence in healthcare, delivering state-of-the-art patient care and advancing the boundaries of medical science. 

Qualifications and Expertise: 

The ideal candidate for this fellowship will meet the following qualifications and requirements: 

1. A Ph.D. or M.D. Ph.D. degree in cancer immunology or a related field (awarded within the last 2 years). 
2. A solid record of publications as first authors in peer-reviewed journals. 
3. Proficiency in immunotherapeutics, in vivo preclinical tumor models, rodent handling, and flow cytometry. 
4. Strong experience in relevant laboratory techniques and methodologies. 
5. Excellent writing and communication skills. 
6. High levels of initiative, proactiveness, and a commitment to achieving scientific excellence. 

Research Focus: 

The fellowship will revolve around the development of innovative strategies to elicit potent anti-cancer responses from the immune system. This involves investigating and creating preventive vaccines and therapeutic platforms, pushing the boundaries of our understanding of immunology and cell engineering. The research may include exploring local cell recruitment and reprogramming techniques that hold promise in the fight against cancer. 

Benefits and Support: 

• Financial support in the form of an endowed fellowship. 

• Travel funding available for conferences and collaborative research opportunities. 
• Collaborative work environment within a team of trainees and investigators. 
• Opportunities to provide mentorship and guidance to junior scientists and graduate students. 
• Access to state-of-the-art research facilities and resources. 

Application Process: 

Applicants interested in the Sue Smith and Craig Brown Endowed Postdoctoral Fellowship in Cancer Immunology are encouraged to submit their application materials, including their CV, a cover letter outlining their research interests, contact information for 3 references, and a list of their first-author publications. The selection process will be highly competitive, and candidates with a demonstrated passion for advancing cancer immunology, the qualifications mentioned above, and a strong publication record will be given preference. 

This fellowship provides a unique platform for recent graduates to make a significant impact in the field of cancer immunology and immunotherapy, contribute to groundbreaking research, and gain valuable experience in a collaborative and innovative environment. Join us in the pursuit of advancing cancer immunology and developing transformative approaches to cancer treatment. 

Contacts 

Email: [email protected] 

Webpage: https://grattoni.hmailabs.org/  

The Sue Smith and Craig Brown Endowed Postdoctoral Fellowship in Regenerative Medicine offers a prestigious research opportunity for highly motivated individuals who have recently achieved a M.D. or Ph.D. degree in cell biology, immunology, bioengineering or related fields. The successful candidate will conduct research at the Grattoni Laboratory at the acclaimed Houston Methodist Hospital located in the Texas Medical Center, the world’s largest medical complex at the forefront of medical innovation and research. Research will emphasize cell transplantation for type 1 diabetes and is designed to support the development of innovative cell transplantation platforms aimed at protecting grafts from host immune rejection and ensuring long-term transplant viability and function for a functional cure of type 1 diabetes. 

Overview: The Sue Smith and Craig Brown Endowed Postdoctoral Fellowship in Regenerative Medicine is a prestigious opportunity for highly motivated and qualified individuals who have recently graduated with a Ph.D. or M.D. Ph.D. degree in cell biology, immunology, bioengineering and related fields (within a maximum of 2 years after obtaining their degree). This fellowship is dedicated to individuals seeking to advance their career in the field of regenerative medicine, with a particular emphasis on cell transplantation for type 1 diabetes (T1D). This fellowship is designed to support postdoctoral researchers in developing innovative cell transplantation platforms aimed at protecting grafts from host immune rejection and ensuring long-term transplant viability and function for a functional cure of T1D. 

This fellowship supports individuals to conduct research training in the Grattoni’s Laboratory at the Houston Methodist Hospital, in Houston Texas. Houston Methodist Hospital, situated in the heart of the Texas Medical Center, the world’s largest medical complex, is at the forefront of medical innovation and research. With a strong emphasis on translating cutting-edge biomedical technologies into clinical practice, it stands as a beacon of excellence in healthcare, delivering state-of-the-art patient care and advancing the boundaries of medical science. 

Qualifications and Expertise: 

The ideal candidate for this fellowship will meet the following qualifications and requirements: 

1. A Ph.D. or M.D. Ph.D. degree in cancer immunology or a related field (awarded within the last 2 years). 
2. A solid record of publications as first authors in peer-reviewed journals. 
3. Proficiency in cell biology, in vivo preclinical diabetes models, rodent handling, and flow cytometry. 
4. Applicants with prior experience in cell transplantation for type 1 diabetes and expertise in cell transplantation devices, scaffolds, and biomaterials, as well as islet harvesting will be highly considered. 
5. Strong experience in relevant laboratory techniques and methodologies. 
6. Excellent writing and communication skills. 
7. High levels of initiative, proactiveness, and a commitment to achieving scientific excellence. 

Research Focus: 

The primary focus of this fellowship is to drive the development of innovative cell transplantation platforms that protect grafts from host immune rejection and maintain their long-term viability and function. The research will explore cutting-edge techniques related to localized immunosuppression, pushing the boundaries of current knowledge in regenerative medicine. The fellow will work alongside a team of experienced investigators and fellow trainees and will also provide mentorship and guidance to junior scientists and graduate students. 

Benefits and Support: 

• Financial support in the form of an endowed fellowship. 
• Travel funding available for conferences and collaborative research opportunities. 
• Collaborative work environment within a team of trainees and investigators. 
• Opportunities to provide mentorship and guidance to junior scientists and graduate students. 

• Access to state-of-the-art research facilities and resources. 

Application Process: 

Applicants interested in the Sue Smith and Craig Brown Endowed Postdoctoral Fellowship in Regenerative Medicine are encouraged to submit their application materials, including their CV, a cover letter outlining their research interests, contact information for 3 references, and a list of their first-author publications. The selection process will be highly competitive, and candidates with a demonstrated passion for advancing T1D research, the qualifications mentioned above, and a strong publication record will be given preference. This fellowship provides a unique platform for recent graduates to make a significant impact in the field cell therapeutics, contribute to groundbreaking research, and gain valuable experience in a collaborative and innovative environment. Join us in the pursuit of advancing bioengineering technologies for T1D. 

Contacts: 

Email: [email protected] 

Webpage: https://grattoni.hmailabs.org/